Dr. Rachel Day, board-certified dermatologist specializing in eczema and psoriasis and Chief Medical Officer at Zest Health, was interviewed for a MedCentral article about a recent study examining whether people with atopic dermatitis (eczema) have an increased risk of developing chronic kidney disease (CKD).
The study, a population-based cohort analysis from Taiwan published in The Journal of Dermatology, found that individuals with atopic dermatitis had a higher risk of developing CKD.
In her interview with the reporter, Dr. Day noted that the findings add to a growing body of research linking chronic autoimmune skin conditions like eczema to broader systemic health outcomes. She also highlighted limitations of the study design, including the population studied, and emphasized that additional research in larger and more diverse populations is needed to determine whether the findings apply more broadly.
The article concluded with Dr. Day saying how the study underscored the need for chronic care models that reflect the growing evidence that inflammatory skin diseases can have systemic health impacts beyond the skin.